Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse
Clinical trial NCT00677716 · COMPLETED
Trial details
- NCT number
- NCT00677716
- Sponsor
- Peregrine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2011-09-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.